Depression, fatigue and disability are independently associated with quality of life in patients with multiple Sclerosis: Results of a cross-sectional study

被引:58
作者
Schmidt, Stephan [1 ]
Joestingmeyer, Petra [2 ]
机构
[1] Gemeinschaftspraxis, Neurol, Kolnstr 54, D-53111 Bonn, Germany
[2] Medunit GmbH, Cologne, Germany
关键词
Multiple sclerosis; Quality of life; Depression; Fatigue; Edss; ENDURANCE EXERCISE; INTERFERON BETA-1B; IMPACT; BURDEN; VALIDATION; EMPLOYMENT; PARAMETERS; CAPACITY; FITNESS; COSTS;
D O I
10.1016/j.msard.2019.07.029
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Quality of life (QoL) is significantly impaired in patients with Multiple Sclerosis (MS). As the expanded disability status scale (EDSS) inadequately reflects the impact of clinical symptoms on QoL, the present study aimed to identify factors associated with reduced QoL in MS patients. Design: Single-center cross-sectional study in 260 MS patients. Methods: QoL was assessed by the Multiple Sclerosis International QoL Questionnaire (MusiQoL), depression by the Center for Epidemiological Studies Depression Scale (CES-D scale), and fatigue by the Fatigue Scale for motor function and cognition (FSMC). Results: 79.6% patients were female and 21.4% male. The mean age was 44.5 +/- 11.2 years and the median EDSS 3.0 (range 0.0-8.5). 35.8% had depression and 56.9% moderate to severe fatigue. The mean MusiQoL index score was 73.9 +/- 11.3. Using linear regression, depression, fatigue, family status, physical activity, and occupation were associated with QoL. EDSS was only associated with QoL in patients with an EDSS 0.5.0. Conclusions: Depression, fatigue, family status, physical activity, and occupational status were closely associated with QoL in MS patients. Potential measures to improve QoL include assessment and treatment of depression, physical exercise, and maintaining patients employed in accordance with their physical and mental disabilities.
引用
收藏
页码:262 / 269
页数:8
相关论文
共 49 条
[1]   Relevance of Quality of Life Assessment for Multiple Sclerosis Patients with Memory Impairment [J].
Baumstarck, Karine ;
Reuter, Francoise ;
Boucekine, Mohamed ;
Aghababian, Valerie ;
Klemina, Irina ;
Loundou, Anderson ;
Pelletier, Jean ;
Auquier, Pascal .
PLOS ONE, 2012, 7 (12)
[2]   Is the Concept of Quality of Life Relevant for Multiple Sclerosis Patients with Cognitive Impairment? Preliminary Results of a Cross-Sectional Study [J].
Baumstarck, Karine ;
Pelletier, Jean ;
Aghababian, Valerie ;
Reuter, Francoise ;
Klemina, Irina ;
Berbis, Julie ;
Loundou, Anderson ;
Auquier, Pascal .
PLOS ONE, 2012, 7 (01)
[3]   A review about the impact of multiple sclerosis on health-related quality of life [J].
Benito-León, J ;
Morales, JM ;
Rivera-Navarro, J ;
Mitchell, AJ .
DISABILITY AND REHABILITATION, 2003, 25 (23) :1291-1303
[4]  
Christian Weimar, 2012, LEITLINIEN DIAGNOSTI
[5]  
COLOSIMO C, 1995, ACTA NEUROL SCAND, V92, P353
[6]   Depression is the main determinant of quality of life in multiple sclerosis: A classification-regression (CART) study [J].
D'Alisa, S ;
Miscio, G ;
Baudo, S ;
Simone, A ;
Tesio, L ;
Mauro, A .
DISABILITY AND REHABILITATION, 2006, 28 (05) :307-314
[7]   Multiple sclerosis and physical exercise: recommendations for the application of resistance-, endurance- and combined training [J].
Dalgas, U. ;
Stenager, E. ;
Ingemann-Hansen, T. .
MULTIPLE SCLEROSIS JOURNAL, 2008, 14 (01) :35-53
[8]   Fatigue, mood and quality of life improve in MS patients after progressive resistance training [J].
Dalgas, U. ;
Stenager, E. ;
Jakobsen, J. ;
Petersen, T. ;
Hansen, H. J. ;
Knudsen, C. ;
Overgaard, K. ;
Ingemann-Hansen, T. .
MULTIPLE SCLEROSIS JOURNAL, 2010, 16 (04) :480-490
[9]   Resistance training improves muscle strength and functional capacity in multiple sclerosis [J].
Dalgas, U. ;
Stenager, E. ;
Jakobsen, J. ;
Petersen, T. ;
Hansen, H. J. ;
Knudsen, C. ;
Overgaard, K. ;
ingemann-Hansen, T. .
NEUROLOGY, 2009, 73 (18) :1478-1484
[10]   INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
DUQUETTE, P ;
GIRARD, M ;
DESPAULT, L ;
DUBOIS, R ;
KNOBLER, RL ;
LUBLIN, FD ;
KELLEY, L ;
FRANCIS, GS ;
LAPIERRE, Y ;
ANTEL, J ;
FREEDMAN, M ;
HUM, S ;
GREENSTEIN, JI ;
MISHRA, B ;
MULDOON, J ;
WHITAKER, JN ;
EVANS, BK ;
LAYTON, B ;
SIBLEY, WA ;
LAGUNA, J ;
KRIKAWA, J ;
PATY, DW ;
OGER, JJ ;
KASTRUKOFF, LF ;
MOORE, GRW ;
HASHIMOTO, SA ;
MORRISON, W ;
NELSON, J ;
GOODIN, DS ;
MASSA, SM ;
GUTTERIDGE, E ;
ARNASON, BGW ;
NORONHA, A ;
REDER, AT ;
MARTIA, R ;
EBERS, GC ;
RICE, GPA ;
LESAUX, J ;
JOHNSON, KP ;
PANITCH, HS ;
BEVER, CT ;
CONWAY, K ;
WALLENBERG, JC ;
BEDELL, L ;
VANDENNOORT, S ;
WEINSHENKER, B ;
WEISS, W ;
REINGOLD, S ;
PACHNER, A ;
TAYLOR, W .
NEUROLOGY, 1993, 43 (04) :655-661